Microglia Receptors in Animal Models of Traumatic Brain Injury

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2018 Dec 17

PMID 30554385

Citations 31

Authors

Daniel Younger

Madhuvika Murugan

Kakulavarapu V Rama Rao

Long-Jun Wu

Namas Chandra

Affiliations

Soon will be listed here.

Abstract

Microglia have been implicated as a key mediator of chronic inflammation following traumatic brain injury (TBI). The animal models of TBI vary significantly based on the type of brain injury (focal versus diffuse). This has made it extremely difficult to assess the role of microglia and the window of microglia activation. Hence, the focus of this review is to summarize the time course of microglia activation in various animal models of TBI. The review explores the repertoire of secondary injury mechanisms such as aberrant neurotransmitter release, oxidative stress, blood-brain barrier disruption, and production of pro-inflammatory cytokines that follow microglia activation. Since receptors act as sensors for activation, we highlight certain microglia receptors that have been implicated in TBI pathology, including fractalkine receptor (CX3CR1), purinergic receptor (P2Y12R), Toll-like receptor (TLR4), scavenger receptors, tumor necrosis factor receptor (TNF-1R), interleukin receptor (IL-1R), complement receptors, and peroxisome proliferator-activated receptor (PPAR). In addition to describing their downstream signaling pathways in TBI, we describe the functional consequences of their activation and the implication in behavioral outcomes. Taken together, this review will provide a holistic view of the role of microglia and its receptors in TBI based on animal studies.

Citing Articles

Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration and Pharmacological Treatment Strategies.

Azam M, Jastrzebska B Cells. 2025; 14(1.

PMID: 39791750 PMC: 11720364. DOI: 10.3390/cells14010049.

(+)-Borneol inhibits neuroinflammation and M1 phenotype polarization of microglia in epileptogenesis through the TLR4-NFκB signaling pathway.

Li S, Adamu A, Ye Y, Gao F, Mi R, Xue G Front Neurosci. 2024; 18:1497102.

PMID: 39605791 PMC: 11599196. DOI: 10.3389/fnins.2024.1497102.

Administration of monophosphoryl lipid A shortly after traumatic brain injury blocks the following spatial and avoidance memory loss and neuroinflammation.

Hooshmand M, Sadeghi M, Asoodeh A, Pourbadie H, Mehni M, Sayyah M Sci Rep. 2024; 14(1):29408.

PMID: 39592660 PMC: 11599587. DOI: 10.1038/s41598-024-80331-3.

Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease.

Seplovich G, Bouchi Y, de Rivero Vaccari J, Pareja J, Reisner A, Blackwell L Neural Regen Res. 2024; 20(6):1644-1664.

PMID: 39104096 PMC: 11688549. DOI: 10.4103/NRR.NRR-D-24-00107.

Neurological Manifestations Following Traumatic Brain Injury: Role of Behavioral, Neuroinflammation, Excitotoxicity, Nrf-2 and Nitric Oxide.

Goyal L, Singh S CNS Neurol Disord Drug Targets. 2024; 24(1):47-59.

PMID: 39082170 DOI: 10.2174/0118715273318552240708055413.

References

Taylor C, Bell J, Breiding M, Xu L . Traumatic Brain Injury-Related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2007 and 2013. MMWR Surveill Summ. 2017; 66(9):1-16. PMC: 5829835. DOI: 10.15585/mmwr.ss6609a1. View

Cernak I, Noble-Haeusslein L . Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J Cereb Blood Flow Metab. 2009; 30(2):255-66. PMC: 2855235. DOI: 10.1038/jcbfm.2009.203. View

Maas A, Roozenbeek B, Manley G . Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics. 2010; 7(1):115-26. PMC: 5084118. DOI: 10.1016/j.nurt.2009.10.022. View

Nimmerjahn A, Kirchhoff F, Helmchen F . Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308(5726):1314-8. DOI: 10.1126/science.1110647. View

Huber B, Meabon J, Hoffer Z, Zhang J, Hoekstra J, Pagulayan K . Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunction. Neuroscience. 2016; 319:206-20. PMC: 5274718. DOI: 10.1016/j.neuroscience.2016.01.022. View

Loane D, Kumar A . Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol. 2015; 275 Pt 3:316-327. PMC: 4689601. DOI: 10.1016/j.expneurol.2015.08.018. View

Boche D, Perry V, Nicoll J . Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2012; 39(1):3-18. DOI: 10.1111/nan.12011. View

Ding A, Nathan C, Stuehr D . Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988; 141(7):2407-12. View

Sica A, Schioppa T, Mantovani A, Allavena P . Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006; 42(6):717-27. DOI: 10.1016/j.ejca.2006.01.003. View

10.

Ransohoff R . A polarizing question: do M1 and M2 microglia exist?. Nat Neurosci. 2016; 19(8):987-91. DOI: 10.1038/nn.4338. View

11.

Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S . Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010; 330(6005):841-5. PMC: 3719181. DOI: 10.1126/science.1194637. View

12.

Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K . A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012; 336(6077):86-90. DOI: 10.1126/science.1219179. View

13.

Link V, Gosselin D, Glass C . Mechanisms Underlying the Selection and Function of Macrophage-Specific Enhancers. Cold Spring Harb Symp Quant Biol. 2015; 80:213-21. PMC: 4936825. DOI: 10.1101/sqb.2015.80.027367. View

14.

Butovsky O, Jedrychowski M, Moore C, Cialic R, Lanser A, Gabriely G . Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci. 2013; 17(1):131-43. PMC: 4066672. DOI: 10.1038/nn.3599. View

15.

Chiu C, Liao Y, Yang L, Wang J, Tweedie D, Karnati H . Neuroinflammation in animal models of traumatic brain injury. J Neurosci Methods. 2016; 272:38-49. PMC: 5201203. DOI: 10.1016/j.jneumeth.2016.06.018. View

16.

Deselms H, Maggio N, Rubovitch V, Chapman J, Schreiber S, Tweedie D . Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development. J Neurosci Methods. 2016; 272:69-76. PMC: 5878044. DOI: 10.1016/j.jneumeth.2016.02.002. View

17.

Xiong Y, Mahmood A, Chopp M . Animal models of traumatic brain injury. Nat Rev Neurosci. 2013; 14(2):128-42. PMC: 3951995. DOI: 10.1038/nrn3407. View

18.

Dixon C, Clifton G, Lighthall J, Yaghmai A, Hayes R . A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods. 1991; 39(3):253-62. DOI: 10.1016/0165-0270(91)90104-8. View

19.

Lighthall J . Controlled cortical impact: a new experimental brain injury model. J Neurotrauma. 1988; 5(1):1-15. DOI: 10.1089/neu.1988.5.1. View

20.

Smith D, Soares H, Pierce J, Perlman K, Saatman K, Meaney D . A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects. J Neurotrauma. 1995; 12(2):169-78. DOI: 10.1089/neu.1995.12.169. View